E 643

Known as: E-643, E643 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1977-1988
012319771988

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1986
1986
The acute hemodynamic effect of the selective alpha1-antagonist, 2-[4-(n-butyryl)-homopiperazine-1-y1]-4-amino-6,7-dimethoxy… (More)
Is this relevant?
1983
1983
The alpha-adrenoceptor activity of (-)-amidephrine in the isolated vas deferens of the rat was characterized. In this preparation… (More)
Is this relevant?
1982
1982
Radiolabeled E-643, a newly developed antihypertensive compound, bound specifically to a preparation obtained from rat brain with… (More)
Is this relevant?
1982
1982
Noradrenaline(NA) inhibited the contractile responses of longitudinal and circular muscles of canine small intestine to field… (More)
Is this relevant?
1981
1981
Effectiveness of E-643, a newly developed alpha-blocker, and four alpha-antagonists in blocking pre- and postsynaptic alpha… (More)
Is this relevant?
1981
1981
To determine whether E-643, a new α-blocking agent, would reduce the blood pressure, regardless of the posture, a 1 mg dose was… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
1981
1981
Using the isolated and blood-perfused dog atrial preparation, chronotropic and inotropic responses to 3 kinds of alpha-adrenergic… (More)
Is this relevant?
1980
1980
Postsynaptic alpha-receptor blocking properties of E-643 were studied in vivo and in vitro and compared with these same… (More)
Is this relevant?
1980
1980
The effect of 2-[N-(n-butyloyl)homopiperazin-N'-yl]-4-amino-6,7-dimethoxy quinazoline hydrochloride (E-643), a new alpha… (More)
Is this relevant?
1977
1977
Using a continuous systolic monitor, effects of oral administration of three alpha-adrenergic blockers, i.e. phenoxybenzamine… (More)
Is this relevant?